nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients
|
Bent-Ennakhil, Nawal |
|
2017 |
6 |
1 |
p. 131-144 |
artikel |
2 |
Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database
|
Boster, Aaron |
|
2017 |
6 |
1 |
p. 91-102 |
artikel |
3 |
Depression Among HIV/AIDS Patients on Highly Active Antiretroviral Therapy in the Southwest Regional Hospitals of Cameroon: A Cross-Sectional Study
|
Ngum, Pleasure Atoh |
|
2017 |
6 |
1 |
p. 103-114 |
artikel |
4 |
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study
|
Malucchi, Simona |
|
2016 |
6 |
1 |
p. 145-152 |
artikel |
5 |
Informal Care Time and Cost in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease: Determinants and Level of Change Observed
|
Lacey, Loretto |
|
2016 |
6 |
1 |
p. 11-23 |
artikel |
6 |
Natalizumab for Achieving Relapse-Free, T1 Gadolinium-Enhancing-Lesion-Free, and T2 Lesion-Free Status in Japanese Multiple Sclerosis Patients: A Phase 2 Trial Subanalysis
|
Saida, Takahiko |
|
2017 |
6 |
1 |
p. 153-159 |
artikel |
7 |
Number Needed to Treat in Multiple Sclerosis Clinical Trials
|
Okwuokenye, Macaulay |
|
2017 |
6 |
1 |
p. 1-9 |
artikel |
8 |
Prescription Patterns of Medications for Alzheimer’s Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database Study
|
Kadohara, Kimiko |
|
2016 |
6 |
1 |
p. 25-37 |
artikel |
9 |
Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS Patients
|
Lee, Andrew |
|
2017 |
6 |
1 |
p. 79-90 |
artikel |
10 |
Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study
|
Dennis, Michael |
|
2017 |
6 |
1 |
p. 57-77 |
artikel |
11 |
Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial
|
Saida, Takahiko |
|
2016 |
6 |
1 |
p. 39-55 |
artikel |
12 |
Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study
|
Sikirica, Vanja |
|
2017 |
6 |
1 |
p. 115-130 |
artikel |